Search - tctmd.com

Displaying 1 - 20 of 99

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Daily News

Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention

Todd Neale

August 25, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

L.A. McKeown

December 09, 2024

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Conference News AHA 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Shelley Wood

November 13, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

Advertisement

TCTMD’s Top 10 Most Popular Stories for January 2026

Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

June 2025 Dispatch for the CV Team

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Statins Are Cost-effective in the Elderly

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Who Benefits Most From Semaglutide and How Long Will That Take?

December 2023 Dispatch for the CV Team

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Vast Majority of HFrEF Patients Eligible for Vericiguat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content